Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 08:37 am Purchase | 2023-12-31 | 13G | Bicycle Therapeutics plc BCYC | Deep Track Capital, LP | 3,490,506 9.250% | 671,461 (+23.82%) | Filing History |
| 2024-02-12 4:10 pm Purchase | 2024-01-31 | 13G | Bicycle Therapeutics plc BCYC | Baker Bros. Advisors LP | 4,823,598 12.800% | 4,823,598 (New Position) | Filing History |
| 2024-02-12 11:59 am Sale | 2023-12-31 | 13G | Bicycle Therapeutics plc BCYC | JANUS HENDERSON GROUP PLC JHG | 0 0.000% | -1,503,447 (Position Closed) | Filing History |
| 2023-07-19 6:29 pm Unchanged | 2023-07-17 | 13D | Bicycle Therapeutics plc BCYC | GSK plc | 1,529,561 4.400% | 0 (Unchanged) | Filing History |
| 2023-02-24 4:54 pm Purchase | 2023-02-14 | 13G | Bicycle Therapeutics plc BCYC | Paradigm BioCapital Advisors LP | 1,610,665 5.400% | 1,610,665 (New Position) | Filing History |
| 2023-02-14 4:09 pm Sale | 2022-12-31 | 13G | Bicycle Therapeutics plc BCYC | Point72 Asset Management, L.P. | 1,021,168 3.400% | -551,655 (-35.07%) | Filing History |
| 2023-02-14 4:07 pm Sale | 2022-12-31 | 13G | Bicycle Therapeutics plc BCYC | Logos Global Management LP | 1,435,000 4.800% | -115,000 (-7.42%) | Filing History |
| 2023-02-14 4:06 pm Unchanged | 2022-12-31 | 13G | Bicycle Therapeutics plc BCYC | Ridgeback Capital Investments L.P. | 2,264,801 7.600% | 0 (Unchanged) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Bicycle Therapeutics plc BCYC | Ridgeback Capital Investments L.P. | 2,264,801 7.600% | 100,000 (+4.62%) | Filing History |
| 2023-02-14 08:31 am Purchase | 2022-12-31 | 13G | Bicycle Therapeutics plc BCYC | Deep Track Capital, LP | 2,819,045 9.500% | 1,322,907 (+88.42%) | Filing History |
| 2023-02-10 10:04 am Sale | 2022-12-31 | 13G | Bicycle Therapeutics plc BCYC | JANUS HENDERSON GROUP PLC JHG | 1,503,447 5.100% | -191,962 (-11.32%) | Filing History |
| 2022-05-02 4:02 pm Purchase | 2022-04-20 | 13G | Bicycle Therapeutics plc BCYC | Logos Global Management LP | 1,550,000 5.200% | 680,000 (+78.16%) | Filing History |
| 2022-03-14 09:29 am Sale | 2022-03-08 | 13D | Bicycle Therapeutics plc BCYC | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,408,259 4.800% | -549,702 (-28.08%) | Filing History |
| 2022-02-14 4:40 pm Purchase | 2021-12-31 | 13G | Bicycle Therapeutics plc BCYC | Point72 Asset Management, L.P. | 1,572,823 5.300% | 135,247 (+9.41%) | Filing History |
| 2022-02-14 4:13 pm Purchase | 2021-12-31 | 13G | Bicycle Therapeutics plc BCYC | Ridgeback Capital Investments L.P. | 2,164,801 7.400% | 302,968 (+16.27%) | Filing History |
| 2022-02-14 3:16 pm Sale | 2021-12-31 | 13G | Bicycle Therapeutics plc BCYC | Logos Global Management LP | 870,000 3.000% | -630,000 (-42.00%) | Filing History |
| 2022-02-11 4:32 pm Sale | 2021-12-31 | 13G | Bicycle Therapeutics plc BCYC | Novartis Bioventures Ltd | 673,360 2.290% | -967,786 (-58.97%) | Filing History |
| 2022-02-11 1:58 pm Purchase | 2021-12-31 | 13G | Bicycle Therapeutics plc BCYC | JANUS HENDERSON GROUP PLC JHG | 1,695,409 5.800% | 1,695,409 (New Position) | Filing History |
| 2022-01-27 4:35 pm Purchase | 2022-01-24 | 13G | Bicycle Therapeutics plc BCYC | Deep Track Capital, LP | 1,496,138 5.090% | 1,496,138 (New Position) | Filing History |
| 2021-09-16 5:22 pm Sale | 2021-08-05 | 13D | Bicycle Therapeutics plc BCYC | GSK plc | 1,529,561 6.000% | -86,734 (-5.37%) | Filing History |